Jennifer R Diamond

Publication Activity (10 Years)

Years Active: 2018-2023
Publications (10 Years): 5

Top Topics

Squamous Cell Carcinoma

Radiation Therapy

Metastatic Breast Cancer

Top Venues

Breast cancer research and treatment

JCO precision oncology

Breast cancer research : BCR

Clinical cancer research : an official journal of the American Association for Cancer Research

This page only lists publications with an associated author ORCID identifier.

Publications

Michael L Cheng, Yeying Huang, Nhi Luong, Jaclyn LoPiccolo, Mizuki Nishino, Lynette M Sholl, Lucian R Chirieac, Alison D Santucci, Michael S Rabin, Pasi A Janne, Shodeinde Coker, Jennifer R Diamond, John Hilton, Geoffrey I Shapiro, Christopher A French
Exceptional Response to Bromodomain and Extraterminal Domain Inhibitor Therapy With BMS-986158 in BRD4-NUTM1 NUT Carcinoma Harboring a BRD4 Splice Site Mutation. JCO precision oncology 7 (2023)
Elena Shagisultanova, William J Gradishar, Ursa Brown-Glabberman, Pavani Chalasani, Andrew J Brenner, Alison T Stopeck, Hannah Parris, Dexiang Gao, Tessa Mcspadden, Jose Mayordomo, Jennifer R Diamond, Peter Kabos, Virginia F Borges
Safety and efficacy of tucatinib, letrozole and palbociclib in patients with previously treated HR+/HER2+ breast cancer. Clinical cancer research : an official journal of the American Association for Cancer Research (2023)
Anna R Schreiber, Jodi Kagihara, Megan Eguchi, Peter Kabos, Christine M Fisher, Elisabeth Meyer, Elizabeth Molina, Lavanya Kondapalli, Cathy J Bradley, Jennifer R Diamond
Evaluating anthracycline + taxane versus taxane-based chemotherapy in older women with node-negative triple-negative breast cancer: a SEER-Medicare study. Breast cancer research and treatment (2021)
Jennifer R Diamond, Carlos Becerra, Donald Richards, Alain Mita, Cynthia Osborne, Joyce O'Shaughnessy, Chun Zhang, Randall Henner, Ann M Kapoun, Lu Xu, Bob Stagg, Shailaja Uttamsingh, Rainer K Brachmann, Azeez Farooki, Monica Mita
Phase Ib clinical trial of the anti-frizzled antibody vantictumab (OMP-18R5) plus paclitaxel in patients with locally advanced or metastatic HER2-negative breast cancer. Breast cancer research and treatment 184 (1) (2020)
Jennifer R Diamond, S G Eckhardt, Todd M Pitts, Adrie van Bokhoven, Dara Aisner, Daniel L Gustafson, Anna Capasso, Sharon Sams, Peter Kabos, Kathryn Zolman, Tiffany Colvin, Anthony D Elias, Anna M Storniolo, Bryan P Schneider, Dexiang Gao, John J Tentler, Virginia F Borges, Kathy D Miller
A phase II clinical trial of the Aurora and angiogenic kinase inhibitor ENMD-2076 for previously treated, advanced, or metastatic triple-negative breast cancer. Breast cancer research : BCR 20 (1) (2018)